{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:18:12Z","timestamp":1782173892256,"version":"3.54.5"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Upregulation of the two-pore-domain potassium channel TASK-1 (hK<jats:sub>2<\/jats:sub><jats:sub><jats:italic>P<\/jats:italic><\/jats:sub>3.1) was recently described in patients suffering from atrial fibrillation (AF) and resulted in shortening of the atrial action potential. In the human heart, TASK-1 channels facilitate repolarization and are specifically expressed in the atria. In the present study, we tested the antiarrhythmic effects of the experimental ion channel inhibitor A293 that is highly affine for TASK-1 in a porcine large animal model of persistent AF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Persistent AF was induced in German landrace pigs by right atrial burst stimulation via implanted pacemakers using a biofeedback algorithm over 14 days. Electrophysiological and echocardiographic investigations were performed before and after the pharmacological treatment period. A293 was intravenously administered once per day. After a treatment period of 14 days, atrial cardiomyocytes were isolated for patch clamp measurements of currents and atrial action potentials. Hemodynamic consequences of TASK-1 inhibition were measured upon acute A293 treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In animals with persistent AF, the A293 treatment significantly reduced the AF burden (6.5% vs. 95%; <jats:italic>P<\/jats:italic> &amp;lt; 0.001). Intracardiac electrophysiological investigations showed that the atrial effective refractory period was prolonged in A293 treated study animals, whereas, the QRS width, QT interval, and ventricular effective refractory periods remained unchanged. A293 treatment reduced the upregulation of the TASK-1 current as well as the shortening of the action potential duration caused by AF. No central nervous side effects were observed. A mild but significant increase in pulmonary artery pressure was observed upon acute TASK-1 inhibition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Pharmacological inhibition of atrial TASK-1 currents exerts <jats:italic>in vivo<\/jats:italic> antiarrhythmic effects that can be employed for rhythm control in a porcine model of persistent AF. Care has to be taken as TASK-1 inhibition may increase pulmonary artery pressure levels.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphys.2020.629421","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T06:06:55Z","timestamp":1611209215000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["The Experimental TASK-1 Potassium Channel Inhibitor A293 Can Be Employed for Rhythm Control of Persistent Atrial Fibrillation in a Translational Large Animal Model"],"prefix":"10.3389","volume":"11","author":[{"given":"Felix","family":"Wiedmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Beyersdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin I.","family":"Foerster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"El-Battrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Borggrefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter E.","family":"Haefeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1161\/circulationaha.115.020951","article-title":"Potassium channel subfamily K member 3 (KCNK3) contributes to the development of pulmonary arterial hypertension.","volume":"133","author":"Antigny","year":"2016","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.tips.2008.07.013","article-title":"Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact.","volume":"29","author":"Bayliss","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"B3","first-page":"353","article-title":"An analysis of time relations of electrocardiograms.","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"key":"B4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.expneurol.2012.08.021","article-title":"The TASK1 channel inhibitor A293 shows efficacy in a mouse model of multiple sclerosis.","volume":"238","author":"Bittner","year":"2012","journal-title":"Exp. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1124\/mol.115.100107","article-title":"Breathing stimulant compounds inhibit TASK-3 potassium channel function likely by binding at a common site in the channel pore.","volume":"88","author":"Chokshi","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1213\/ane.0b013e318284469d","article-title":"TASK-1 (KCNK3) and TASK-3 (KCNK9) Tandem pore potassium channel antagonists stimulate breathing in isoflurane-anesthetized rats.","volume":"116","author":"Cotton","year":"2013","journal-title":"Anesth. Analg."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13361","article-title":"Effects of the ventilatory stimulant, doxapram on human TASK-3 (KCNK9, K2P9.1) channels and TASK-1 (KCNK3, K2P3.1) channels.","volume":"228","author":"Cunningham","year":"2019","journal-title":"Acta Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/fjc.0b013e3181669030","article-title":"Characterization of human cardiac Kv1.5 inhibition by the novel atrial-selective antiarrhythmic compound AVE1231.","volume":"51","author":"Ehrlich","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/35058574","article-title":"Potassium leak channels and the KCNK family of two-P-domain subunits.","volume":"2","author":"Goldstein","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"ESC Scientific Document Group, 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.","author":"Hindricks","year":"2020","journal-title":"Eur. Heart J."},{"key":"B11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines and the heart rhythm society.","volume":"74","author":"January","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00424-014-1665-1","article-title":"Kv1.5 blockers preferentially inhibit TASK-1 channels: TASK-1 as a target against atrial fibrillation and obstructive sleep apnea?","volume":"467","author":"Kiper","year":"2015","journal-title":"Pflugers Arch."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00177","article-title":"Hemodynamic and pathologic characterization of the TASK-1\u2013\/\u2013 mouse does not demonstrate pulmonary hypertension.","volume":"4","author":"Kitagawa","year":"2017","journal-title":"Front. Med. (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1159\/000335757","article-title":"TASK-1 channels may modulate action potential duration of human atrial cardiomyocytes.","volume":"28","author":"Limberg","year":"2011","journal-title":"Cell. Physiol. Biochem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1161\/hypertensionaha.111.175349","article-title":"Disruption of K2P6.1 produces vascular dysfunction and hypertension in mice.","volume":"58","author":"Lloyd","year":"2011","journal-title":"Hypertension"},{"key":"B16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa1211097","article-title":"A novel channelopathy in pulmonary arterial hypertension.","volume":"69","author":"Ma","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174071","article-title":"TASK-1 potassium channel is not critically involved in mediating hypoxic pulmonary vasoconstriction of murine intra-pulmonary arteries.","volume":"12","author":"Murtaza","year":"2017","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1161\/01.cir.58.4.706","article-title":"A new method for measurement of sinoatrial conduction time.","volume":"58","author":"Narula","year":"1978","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/circep.107.754564","article-title":"Atrial remodeling and atrial fibrillation: mechanisms and implications.","volume":"1","author":"Nattel","year":"2008","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13876","article-title":"A1899, PK-THPP, ML365, and Doxapram inhibit endogenous TASK channels and excite calcium signaling in carotid body type-1 cells.","volume":"6","author":"O\u2019Donohoe","year":"2018","journal-title":"Physiol. Rep."},{"key":"B21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.RES.0000219677.12988.e9","article-title":"Impact of TASK-1 in human pulmonary artery smooth muscle cells.","volume":"98","author":"Olschewski","year":"2006","journal-title":"Circ. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1183\/09031936.01.00204001","article-title":"Molecular physiology of oxygen-sensitive potassium channels.","volume":"18","author":"Patel","year":"2001","journal-title":"Eur. Respir. J."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104262","article-title":"Atria-selective antiarrhythmic drugs in need of alliance partners.","volume":"145","author":"Peyronnet","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B24","doi-asserted-by":"crossref","first-page":"C1319","DOI":"10.1152\/ajpcell.00100.2007","article-title":"Differential effects of volatile and intravenous anesthetics on the activity of human TASK-1.","volume":"293","author":"Putzke","year":"","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cardiores.2007.02.025","article-title":"The acid-sensitive potassium channel TASK-1 in rat cardiac muscle.","volume":"75","author":"Putzke","year":"","journal-title":"Cardiovasc. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.yjmcc.2015.01.017","article-title":"TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes.","volume":"81","author":"Rinn\u00e9","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41586-020-2250-8","article-title":"A lower X-gate in TASK channels traps inhibitors within the vestibule.","volume":"582","author":"R\u00f6dstr\u00f6m","year":"2020","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.119.007465","article-title":"Genetic ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K+ Channel-Related Acid-Sensitive K+ Channel-1) (K2P3.1) K+ channels suppresses atrial fibrillation and prevents electrical remodeling.","volume":"12","author":"Schmidt","year":"2019","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.hrthm.2014.06.020","article-title":"Cloning, functional characterization, and remodeling of K2P3.1 (TASK-1) potassium channels in a porcine model of atrial fibrillation and heart failure.","volume":"11","author":"Schmidt","year":"2014","journal-title":"Heart Rhythm"},{"key":"B30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ejphar.2013.09.029","article-title":"Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K+ K2P channels.","volume":"721","author":"Schmidt","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/circulationaha.114.012657","article-title":"Upregulation of K2P3.1 K+ current causes action potential shortening in patients with chronic atrial fibrillation.","volume":"132","author":"Schmidt","year":"2015","journal-title":"Circulation"},{"key":"B32","first-page":"1764","article-title":"Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy.","volume":"38","author":"Schmidt","year":"2017","journal-title":"Eur. Heart J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1152\/physrev.00031.2009","article-title":"Pathophysiological mechanisms of atrial fibrillation: a translational appraisal.","volume":"91","author":"Schotten","year":"2011","journal-title":"Physiol. Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1161\/01.cir.47.1.86","article-title":"Premature atrial stimulation as a key to the understanding of sinoatrial conduction in man.","volume":"47","author":"Strauss","year":"1973","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015751","article-title":"The pharmacologic TWIK-related acid- sensitive K+ (TASK-1) potassium channel inhibitor A293 facilitates acute cardioversion of paroxysmal atrial fibrillation in a porcine large animal model.","volume":"9","author":"Wiedmann","year":"","journal-title":"J. Am. Heart Assoc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.33594\/000000083","article-title":"Identification of the A293 (AVE1231) binding site in the cardiac two-pore-domain potassium channel TASK-1: a common low affinity antiarrhythmic drug binding site.","volume":"52","author":"Wiedmann","year":"2019","journal-title":"Cell Physiol. Biochem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"S0079","DOI":"10.1016\/j.pbiomolbio.2020.05.007","article-title":"Mechanosensitive TREK-1 two-pore-domain potassium (K2P) channels in the cardiovascular system.","volume":"15","author":"Wiedmann","year":"","journal-title":"Progr. Biophys. Mol. Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/fjc.0b013e318032002f","article-title":"In vitro and in vivo effects of the atrial selective antiarrhythmic compound AVE1231.","volume":"49","author":"Wirth","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2020.629421\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T06:06:59Z","timestamp":1611209219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2020.629421\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":38,"alternative-id":["10.3389\/fphys.2020.629421"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2020.629421","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,21]]},"article-number":"629421"}}